Viewing Study NCT01194193

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:10 AM
Ignite Modification Date: 2026-01-01 @ 12:19 AM
Study NCT ID: NCT01194193
Status: WITHDRAWN
Last Update Posted: 2011-05-16
First Post: 2010-08-18
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Preliminary Anti-tumour Activity of mTor Kinase Inhibitor in Advanced Tumours
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
None Advanced Solid Tumours View
None Lymphomas View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cancer View
None Advanced solid tumours View
None lymphomas View
None dose escalation View
None preliminary anti-tumour activity View
None Tor kinase inhibitor View
None oral administration View
None intermittent dosing View